REM sleep behavior disorder

There are 92 papers on REM sleep behavior disorder in aging research: 1 trial and 63 observational studies in people, 1 in animals, 25 reviews. The newest story, Nov 19, 2026: “Diabetes drug classes linked to Parkinson’s risk in a sleep disorder”.

Disease

92 papers study it85 more mention it27 findings

MeSH

12 new papers in 30 daysSee all 177 papers on REM sleep behavior disorder

“Agent Orange exposure was associated with higher risk of PD (hazard ratio [HR], 1.44; 95% CI, 1.37-1.52), RBD (HR, 1.78; 95% CI, 1.68-1.89)”
Agent Orange Exposure and Diagnosis of Parkinson Disease and Related Disorders Among US VeteransJAMA neurology2026doi:10.1001/jamaneurol.2026.4219
  • Human trial1
  • Humans63
  • Animals1

Interventions

3

Exercise

downin humans1

1 study
  1. Exercise protects against REM sleep behavior disorder in REM sleep behavior disorder and Parkinson's disease.

    “Exercise exerts neuroprotective effects for RBD through multiple underlying mechanisms.”

    Reviewin REM sleep behavior disorder and Parkinson's disease

    Exercise Intervention for REM Sleep Behavior Disorder in Parkinson's Disease: Mechanisms and Implications for Neurorehabilitation

    CNS neuroscience & therapeutics

More on Exercise

DORA-12

downin mice1

1 study
  1. DORA-12 decreases REM sleep behavior disorder in aged PS19 mice.

    “We observed a significant effect of DORA-12 on objective measures of RBD”

    Animalsin aged PS19 mice

    Effect of Aging and a Dual Orexin Receptor Antagonist on Sleep Architecture and Non-REM Oscillations Including an REM Behavior Disorder Phenotype in the PS19 Mouse Model of Tauopathy

    The Journal of neuroscience : the official journal of the Society for Neuroscience

More on DORA-12

Clonazepam

downin humans1

1 study
  1. Clonazepam decreases REM sleep behavior disorder in humans (REM sleep behavior disorder).

    “RBD usually responds to therapy consisting mainly of melatonin and/or clonazepam at bedtime.”

    ReviewREM sleep behavior disorder

    REM sleep behavior disorder as a complex condition with heterogeneous underlying disorders: clinical management and prognostic implications [Commentary]

    Sleep & breathing = Schlaf & Atmung

More on Clonazepam

Effects

5

Gait variability and dual task cost

no changein humans1

1 study
  1. REM sleep behavior disorder was not clearly linked with gait variability and dual task cost in humans (RBD compared with controls at baseline).

    “No differences in gait variability or cost were identified between RBD and control groups at baseline.”

    HumansRBD compared with controls at baselinen = 46

    An examination of the effect of dual task on gait in Parkinson's disease and REM sleep behavior disorder

    Parkinsonism & related disorders

Gait velocity

downin humans1

1 study
  1. REM sleep behavior disorder is linked with lower gait velocity in humans (compared to controls).

    “normalized gait velocity and walking endurance were significantly decreased in iRBD patients compared to controls”

    Humanscompared to controls

    Gait dysfunction as an early marker of phenoconversion in REM sleep behavior disorder

    Scientific reports

Dynamic balance

downin humans1

1 study
  1. REM sleep behavior disorder is linked with worse dynamic balance in humans (without parkinsonian motor signs).

    “trunk movement coordination (bend, twist and touch test) and dynamic balance (line walk test) without alterations in simple motor speed”

    Humanswithout parkinsonian motor signs

    Systematic quantitative assessment of motor function in clinically isolated REM sleep behaviour disorder: A diagnostic window into early alpha-synucleinopathies

    Journal of sleep research

Trunk movement coordination

downin humans1

1 study
  1. REM sleep behavior disorder is linked with worse trunk movement coordination in humans (without parkinsonian motor signs).

    “Patients with iRBD showed abnormalities in perceptual motor speed (falling stick test), trunk movement coordination (bend, twist and touch test) and dynamic balance (line walk test)”

    Humanswithout parkinsonian motor signs

    Systematic quantitative assessment of motor function in clinically isolated REM sleep behaviour disorder: A diagnostic window into early alpha-synucleinopathies

    Journal of sleep research

Perceptual-motor speed

downin humans1

1 study
  1. REM sleep behavior disorder is linked with worse perceptual-motor speed in humans (without parkinsonian motor signs) (ROC-AUC 0.85, p <= 0.001).

    “The falling stick test showed the highest diagnostic accuracy in identifying subjects with RBD (ROC-AUC 0.85, p ≤ 0.001).”

    Humanswithout parkinsonian motor signs

    Systematic quantitative assessment of motor function in clinically isolated REM sleep behaviour disorder: A diagnostic window into early alpha-synucleinopathies

    Journal of sleep research

Associations

14

Synucleinopathies

upin humans3

3 studies
  1. REM sleep behavior disorder predicts synucleinopathies in humans with early neuropsychiatric symptoms.

    “presence of TCSR, associated with early neuropsychiatric symptoms, indicates a high probability of conversion to neurodegenerative diseases”

    Reviewwith early neuropsychiatric symptoms

    REM Sleep Disorder as a Predictor of Synucleinopathies with Psychiatric Manifestations

    Nursing Edição Brasileira

  2. REM sleep behavior disorder predicts synucleinopathies in humans.

    “RBD is potentially a crucial early indicator for synucleinopathies (brain diseases that are related to the accumulation of alpha-synuclein protein).”

    Review

    REM sleep behavior disorder and synucleinopathies

    Progress in brain research

  3. REM sleep behavior disorder is associated with synucleinopathies in humans.

    “there is a strong association of RBD with diseases caused by the deposition of alpha-synuclein in neurons (synucleinopathies)”

    Review

    REM sleep behavior disorder: update on diagnosis and management

    Arquivos de neuro-psiquiatria

More on Synucleinopathies

Neurodegenerative disease

upin humans3

3 studies
  1. REM sleep behavior disorder is associated with neurodegenerative disease in humans.

    “The results demonstrated that TSREM has an important relationship with neurodegenerative processes associated with the accumulation of neurotoxic proteins”

    Review

    REM Sleep Disorder and Its Link to Neurological Diseases

    Periódicos Brasil Pesquisa Científica

  2. REM sleep behavior disorder is associated with neurodegenerative disease in humans.

    “RBD is clearly an at-risk population for neurodegenerative disease”

    Review

    REM Sleep Behavior Disorder as a Prodromal Synucleinopathy: Updates on Clinical and Laboratory Biomarkers, and Implications for Neuroprotective Trials

    Current neurology and neuroscience reports

  3. REM sleep behavior disorder is associated with neurodegenerative disease in humans (isolated REM sleep behavior disorder) (Median latency to neurodegenerative disease diagnosis: 8 years).

    “Isolated RBD is strongly linked with neurodegenerative disorders, particularly α-synucleinopathies, with a median latency to neurodegenerative disease diagnosis of 8 years.”

    Reviewisolated REM sleep behavior disorder

    REM Sleep Behavior Disorder and Other REM Parasomnias

    Continuum (Minneapolis, Minn.)

More on Neurodegenerative disease

Parkinson's disease

upin humans2

2 studies
  1. REM sleep behavior disorder predicts Parkinson's disease in older people with tremor.

    “Probable REM sleep behavior disorder (RBD), identified using the RBD Questionnaire-Hong Kong, and self-report of new-onset rest tremor predicted PD conversion.”

    Humansin older people with tremor7.7 yearsn = 202

    Risk of Parkinson's disease in older people with tremor: A population-based prospective study

    Journal of Parkinson's disease

  2. REM sleep behavior disorder is associated with Parkinson's disease in humans (idiopathic REM sleep behavior disorder).

    “evolution of iRBD to PD/DLB in most middle-aged and older patients over a period of years to several decades”

    Reviewidiopathic REM sleep behavior disorder

    REM sleep behavior disorder as a complex condition with heterogeneous underlying disorders: clinical management and prognostic implications [Commentary]

    Sleep & breathing = Schlaf & Atmung

More on Parkinson's disease

Agent orange

upin humans1HR 1.78

1 study
  1. Agent orange is associated with REM sleep behavior disorder in humans (US veterans who served during the Vietnam War Era) (HR 1.78, 95% CI 1.68–1.89).

    “Agent Orange exposure was associated with higher risk of PD (hazard ratio [HR], 1.44; 95% CI, 1.37-1.52), RBD (HR, 1.78; 95% CI, 1.68-1.89)”

    HumansUS veterans who served during the Vietnam War EraMean follow-up of 12.5 years98% malesn = 4,468,509

    Agent Orange exposure linked to Parkinson disease in US veterans

    JAMA neurology

More on Agent orange

Alpha-synucleinopathy

upin reviews1

1 study
  1. REM sleep behavior disorder predicts alpha-synucleinopathy.

    “The studies analyzed presented relevant results regarding the prognostic value of TCSREM in the early identification of α-synucleinopathies.”

    Review

    REM sleep behavior disorder as an early and prognostic marker of neurodegenerative diseases: an integrative literature review

    Revista Brasileira de Saúde

More on Alpha-synucleinopathy

Single-channel mastoid exg

upin humans1

1 study
  1. Single-channel mastoid exg predicts REM sleep behavior disorder in humans (AUC 0.95).

    “In self-applied home recordings from 76 participants, the 1-channel system detected RBD with an AUC of 0.95”

    Humansn = 76

    Self-applied single-channel mastoid ExG for fully automated detection of REM sleep behaviour disorder

    medRxivPreprint

More on Single-channel mastoid exg

PAT model score

upin humans1

1 study
  1. PAT model score predicts REM sleep behavior disorder in patients with PD (PD-RBD vs PD-noRBD) (AUC = 0.956).

    “In the PD-RBD versus PD-noRBD classification task, the PAT model again outperformed the other models (AUC = 0.956, sensitivity = 84.4% and specificity = 92.9%).”

    Humansin patients with PD (PD-RBD vs PD-noRBD)

    Movement-based model distinguished Parkinson’s disease

    Journal of sleep research

More on PAT model score

Actitect

upin silico1

1 study
  1. Actitect predicts REM sleep behavior disorder in silico under nested cross-validation (AUROC = 0.95).

    “Model development was conducted on a cohort of 78 individuals, yielding strong discrimination under nested cross-validation (AUROC = 0.95).”

    In silicounder nested cross-validationn = 78

    ActiTect: a generalizable machine learning pipeline for REM sleep behavior disorder screening through standardized actigraphy

    NPJ digital medicine

More on Actitect

Cognitive function

downin humans1

1 study
  1. REM sleep behavior disorder predicts cognitive function in idiopathic RBD.

    “Individuals with idiopathic RBD (iRBD) frequently exhibit early deficits in executive function, attention, visuospatial abilities, and episodic memory-often years before motor symptoms manifest.”

    Reviewin idiopathic RBD

    REM Sleep Behavior Disorder as a Key Predictor of Cognitive Decline: Insights from a Narrative Review

    Sleep science (Sao Paulo, Brazil)

Gait

downin humans1

1 study
  1. REM sleep behavior disorder is associated with gait in humans (at baseline compared with healthy controls).

    “At baseline, iRBD patients exhibited significant gait abnormalities compared with controls.”

    Humansat baseline compared with healthy controls

    Association of wearable sensor-based gait analysis with phenoconversion trajectories in idiopathic REM sleep behavior disorder

    NPJ Parkinson's disease

All 14

Trial sponsors

Funding

8 grants since 2018

National Institute on Aging$5MGouvernement du Canada | Canadian Institutes of Health ResearchCA$35KJapan Society for the Promotion of Science¥4.3M

Contains public sector information licensed under the Open Government Licence v3.0.

Latest

Dec 2025: 8Jan 2026: 2Feb 2026: 3Mar 2026: 7Apr 2026: 7May 2026: 11Jun 2026: 9Jul 2026: 5Aug 2026: 8Sep 2026: 5Oct 2026: 9Nov 2026: 579 papers in 12 months
Journal of Sleep Research

Diabetes drug classes linked to Parkinson’s risk in a sleep disorder

Glucagon-like peptide-1 receptor agonists were linked to lower Parkinson’s risk than dipeptidyl peptidase-4 inhibitors, with a hazard ratio, measuring relative risk, of…Glucagon-like peptide-1 receptor agonists were linked to lower Parkinson’s risk than dipeptidyl peptidase-4 inhibitors, with a hazard ratio, measuring relative risk, of 0.02.

Cohort · 148 peopleParkinsonism
JAMA Neurology

Agent Orange exposure linked to Parkinson disease in US veterans

Compared with unexposed veterans, those reporting exposure had a higher relative risk of Parkinson disease diagnosis, with a hazard ratio of 1.44.Compared with unexposed veterans, those reporting exposure had a higher relative risk of Parkinson disease diagnosis, with a hazard ratio of 1.44.

Cohort · 4,468,509 peopleParkinson's disease
medRxiv

Combined sleep and smell signs linked to Parkinson’s marker

A spinal-fluid test was positive in 94% with a confirmed dream-enactment sleep disorder and reduced smell, versus 40% with the disorder but no reduced smell.A spinal-fluid test was positive in 94% with a confirmed dream-enactment sleep disorder and reduced smell, versus 40% with the disorder but no reduced smell.

Preprint: cohort · 1,652 peopleParkinson's disease
Sleep Medicine

Dopamine loss in sleep disorder predicts Parkinson conversion

In PET scans of 77 patients with isolated REM sleep behavior disorder, quantitative dopamine markers showed intermediate loss and predicted phenoconversion toward…In PET scans of 77 patients with isolated REM sleep behavior disorder, quantitative dopamine markers showed intermediate loss and predicted phenoconversion toward Parkinson's disease.

Cohort study of 194 peopleParkinson's disease
Journal of Neurology

Multimodal PET and MRI predict dementia with Lewy bodies

Combined occipito-parietal cortex pathology and striatal dopamine loss predicted conversion to dementia with Lewy bodies with a sub-distribution hazard ratio of 38.68.Combined occipito-parietal cortex pathology and striatal dopamine loss predicted conversion to dementia with Lewy bodies with a sub-distribution hazard ratio of 38.68.

Cohort study of 21 peopleDementia with Lewy bodies

See all 177 papers on REM sleep behavior disorder